Glimepiride Powder 99.36% Pharmaceutical Raw Materials CAS 93479-97-1
Pharmaceutical Raw Materials Glimepiride Powder,99.36% Glimepiride
Formule moléculaire:C24H34N4O5S
Formule de poid: 490.62
N ° CAS.:93479-97-1
Pureté:99.36%
Apparence: off white powder
Glimepiride (original trade name Amaryl) is an orally available medium-to-long-acting sulfonylurea antidiabetic drug. It is sometimes classified as either the first third-generation sulfonylurea,or as second-generation.
Glimepiride is indicated to treat type 2 diabetes mellitus; its mode of action is to increase insulin production by the pancreas. It is not used for type 1 diabetes because in type 1 diabetes the pancreas is not able to produce insulin.
Its use is contraindicated in patients with hypersensitivity to glimepiride or other sulfonylureas.
The COA:
| Nom du produit |
Glimepiride |
| n ° CAS. |
93479-97-1 |
Emballage extérieur |
25KG/drum |
| Date de production |
2016.7.12 |
Durée de conservation |
2019.07.11 |
| Norme adoptée |
Norme d'entreprise |
| Éléments d'analyse |
spécification |
Résultats |
|
Apparence |
White or off white powder |
off white powder |
|
Solubilité |
Two soluble in dimethylformamide, soluble in dichloromethane two chloride, slightly soluble in methanol, practically insoluble in water |
Conforme |
| Identification |
IR map should be consistent with the control map |
Conforme |
| Heavy metal |
≤10 ppm |
Conforme |
| Cis-isomer(UN) |
≤0.8% |
0.20% |
|
Sulfonamide(B) |
≤0.4% |
0.11% |
| Urethane(C) |
≤0.1% |
ND |
| 3-isomère(D) |
≤0.2% |
ND |
| Any other impurity |
≤0.1% |
0.08% |
| Impuretés totales |
0,5 % |
0.12% |
| Résidu à l'allumage |
≤0.2% |
0.08% |
| Perte au séchage |
0,5 % |
0.16% |
| Essai |
98.0% ～102.0 % |
99.36% |
| Conclusion |
Qualifié |
Directeur commercial